European Respiratory Society statement on thoracic ultrasound.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
03 2021
Historique:
received: 01 05 2020
accepted: 20 08 2020
pubmed: 10 10 2020
medline: 3 7 2021
entrez: 9 10 2020
Statut: epublish

Résumé

Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist. It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for diagnosis, a real-time guide to procedures and a predictor or measurement of treatment response. The aim of this European Respiratory Society task force was to produce a statement on thoracic ultrasound for pulmonologists using thoracic ultrasound within the field of respiratory medicine. The multidisciplinary panel performed a review of the literature, addressing major areas of thoracic ultrasound practice and application. The selected major areas include equipment and technique, assessment of the chest wall, parietal pleura, pleural effusion, pneumothorax, interstitial syndrome, lung consolidation, diaphragm assessment, intervention guidance, training and the patient perspective. Despite the growing evidence supporting the use of thoracic ultrasound, the published literature still contains a paucity of data in some important fields. Key research questions for each of the major areas were identified, which serve to facilitate future multicentre collaborations and research to further consolidate an evidence-based use of thoracic ultrasound, for the benefit of the many patients being exposed to clinicians using thoracic ultrasound.

Identifiants

pubmed: 33033148
pii: 13993003.01519-2020
doi: 10.1183/13993003.01519-2020
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Marie Curie
ID : MCCC-RP-14-A17178
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-0213-30098
Pays : United Kingdom

Informations de copyright

Copyright ©ERS 2021.

Déclaration de conflit d'intérêts

Conflict of interest: C.B. Laursen has nothing to disclose. Conflict of interest: A. Clive has nothing to disclose. Conflict of interest: R. Hallifax has nothing to disclose. Conflict of interest: P.I. Pietersen has nothing to disclose. Conflict of interest: R. Asciak has nothing to disclose. Conflict of interest: J.R. Davidsen has nothing to disclose. Conflict of interest: R. Bhatnagar has nothing to disclose. Conflict of interest: E.O. Bedawi has nothing to disclose. Conflict of interest: N. Jacobsen has nothing to disclose. Conflict of interest: C. Coleman is an employee of the European Lung Foundation. Conflict of interest: A. Edey has nothing to disclose. Conflict of interest: G. Via has nothing to disclose. Conflict of interest: G. Volpicelli has nothing to disclose. Conflict of interest: G. Massard has nothing to disclose. Conflict of interest: F. Raimondi has nothing to disclose. Conflict of interest: M. Evison has nothing to disclose. Conflict of interest: L. Konge has nothing to disclose. Conflict of interest: J. Annema has nothing to disclose. Conflict of interest: N.M. Rahman reports equipment provision from Esaote, Italy, outside the submitted work. Conflict of interest: N. Maskell has nothing to disclose.

Auteurs

Christian B Laursen (CB)

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark christian.b.laursen@rsyd.dk.
Dept of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

Amelia Clive (A)

Academic Respiratory Unit, University of Bristol, Bristol, UK.
Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Rob Hallifax (R)

Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford Respiratory Trials Unit, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.

Pia Iben Pietersen (PI)

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark.
Dept of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Regional Center for Technical Simulation, Odense University Hospital, Odense, Denmark.

Rachelle Asciak (R)

Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford Respiratory Trials Unit, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.

Jesper Rømhild Davidsen (JR)

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark.
Dept of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
South Danish Center for Interstitial Lung Diseases (SCILS), Odense University Hospital, Odense, Denmark.

Rahul Bhatnagar (R)

Academic Respiratory Unit, University of Bristol, Bristol, UK.
Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Eihab O Bedawi (EO)

Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford Respiratory Trials Unit, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.

Niels Jacobsen (N)

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark.
Dept of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Regional Center for Technical Simulation, Odense University Hospital, Odense, Denmark.

Courtney Coleman (C)

European Lung Foundation, Sheffield, UK.

Anthony Edey (A)

Dept of Radiology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Gabriele Via (G)

Cardiac Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland.

Giovanni Volpicelli (G)

Dept of Emergency Medicine, Ospedale San Luigi Gonzaga, Torino, Italy.

Gilbert Massard (G)

Faculty of Science, Technology and Medicine, University of Luxembourg, Grand-Duchy of Luxembourg.

Francesco Raimondi (F)

Division of Neonatology, Section of Pediatrics, Dept of Translational Medical Sciences, Università "Federico II" di Napoli, Naples, Italy.

Matthew Evison (M)

Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Lars Konge (L)

Copenhagen Academy for Medical Education and Simulation, The Capital Region of Denmark, Centre for HR, University of Copenhagen, Copenhagen, Denmark.

Jouke Annema (J)

Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Najib M Rahman (NM)

Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford Respiratory Trials Unit, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Joint last authors.

Nick Maskell (N)

Academic Respiratory Unit, University of Bristol, Bristol, UK.
Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Joint last authors.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH